OncoImmune releases preliminary efficacy results of SACCOVID on severe COVID-19.
People who get infected by Covid-19 can either have symptoms that range from mild to deadly. And now two new studies have said that some life-threatening cases can be traced to weak spots in the immune system of the covid-19…
One of the enduring bits of good news about the coronavirus (COVID-19) pandemic, is that unlike most viral illnesses where the youngest and oldest are most affected — it appears children do not generally have the sever complications adults do.
Could adult stem cells be an answer to COVID-19? There are currently more than 50 clinical trials underway focusing on how adult stem cells could help treat severe COVID-19 patients or lead to vaccine.
The FDA’s recent move to grant emergency use authorization for convalescent plasma as a potential treatment for severe COVID-19 was met with controversy. With many critics pointing out a lack of available data to support the treatment.
A clinical-stage immunology company has an investigational therapy looking to target the cytokine tumor necrosis factor.
